Rockbridge Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-644
| Closed | -$33K | – | 184 |
|
2023
Q4 | $33K | Buy |
+644
| New | +$33K | 0.01% | 279 |
|
2022
Q3 | – | Sell |
-791
| Closed | -$60.9K | – | 166 |
|
2022
Q2 | $60.9K | Sell |
791
-425
| -35% | -$32.7K | 0.01% | 195 |
|
2022
Q1 | $89.8K | Sell |
1,216
-470
| -28% | -$34.7K | 0.01% | 227 |
|
2021
Q4 | $105K | Hold |
1,686
| – | – | 0.02% | 247 |
|
2021
Q3 | $100K | Buy |
1,686
+600
| +55% | +$35.6K | 0.02% | 232 |
|
2021
Q2 | $73K | Buy |
1,086
+100
| +10% | +$6.72K | 0.01% | 262 |
|
2021
Q1 | $62K | Sell |
986
-1,300
| -57% | -$81.7K | 0.01% | 267 |
|
2020
Q4 | $142K | Hold |
2,286
| – | – | 0.03% | 165 |
|
2020
Q3 | $138K | Hold |
2,286
| – | – | 0.03% | 153 |
|
2020
Q2 | $134K | Buy |
+2,286
| New | +$134K | 0.03% | 149 |
|